{"disease":{"id":"bone-marrow-diseases","name":"bone marrow diseases"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07102849","title":"Molecular and Clinical Analysis of Bone Marrow Failure: A Secondary Research Study","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":1400,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT07023692","title":"Visual and Auditory Distraction for the Relief of Pain and Anxiety","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":250,"lead_sponsor_name":"Region Skane","has_results":false},{"nct_id":"NCT03066648","title":"Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":241,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT00001627","title":"Collection of Blood and Bone Marrow From Healthy Volunteers and Patients for Research Purposes","phase":"","overall_status":"COMPLETED","enrollment_count":154,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT00085670","title":"Cytokine Gene Polymorphisms in Bone Marrow Failure","phase":"","overall_status":"COMPLETED","enrollment_count":79,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT01787552","title":"A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT04039100","title":"Family Caregiver Ambassador Support for Family Caregivers of Patients With Hematological Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":43,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT01629082","title":"Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":4,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}